Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: Elevated basal activity and sustained response to EGF

Carcinogenesis

Volumn 20, Issue 7, 1999, Pages 1201-1208

  Xing, Chao ^a   Imagawa, Walter ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL LINE; CELL SIZE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FEMALE; FLAVONOIDS; IMMUNOBLOTTING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TIME FACTORS;

EID: 0032804226     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.7.1201     Document Type: Article

References (48)

1. Dickson, R. and Lippman, M. (1995) Growth factors in breast cancer. Endocrine Rev., 16, 559-589.
2. Kienhuis, C., Sluyser, M., de Goeij, C., Koenders, P. and Benraad, T. (1993) Epidermal growth factor receptor levels increase but epidermal growh factor receptor ligand levels decrease in mouse mammary tumors during progression from hormone dependence to hormone independence. Breast Cancer Res. Treat., 26, 289-295.
3. van Agthoven, T., van Agthoven, T.L.A., Portengen, H., Foekens, J. and Dorssers, L. (1993) Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res., 52, 5082-5088.
4. Schlessinger, J. and Ullrich, A. (1992) Growth factor signaling by receptor tyrosine kinases. Neuron, 9, 383-391.
5. Campbell, J., Seger, R., Graves, J., Graves, L., Jensen, A. and Krebs, E. (1995) The MAP kinase cascade. Rec. Prog. Horm. Res., 50, 131-159.
6. Janes, P., Daly, R., deFazio, A. and Sutherland, R. (1994) Activation of the ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene, 9, 3601-3608.
7. Brunet, A., Pages, G. and Pouyssegur, J. (1994) Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene, 9, 3379-3387.
8. Mansour, S., Matten, W., Hermann, A., Candia, J., Rong, S., Fukasawa, K., Vande Woude, G. and Ahn, N. (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science, 265, 966-970.
9. Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., Kakehi, Y., Terachi, T., Okada, Y., Kawaichi, M., Kohno, M. and Yoshida, O. (1995) Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res., 55, 4182-4187.
10. Sivaraman, V., Wang, H.-y., Nuovo, G. and Malbon, C. (1997) Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest., 99, 1478-1483.
11. Richards, J., Larson, L., Yang, J., Guzman, R., Tomooka, Y., Osborn, R., Imagawa, W. and Nandi, S. (1983) Method for culturing mammary epithelial cells in rat tail collagen matrix. J. Tissue Cult. Meth., 8, 31-36.
12. Price, J., Turner, D. and Cepko, C. (1987) Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl Acad. Sci. USA, 84, 156-160.
13. Imagawa, W., Bandyopadhyay, G., Garcia, M., Matsuzawa, A. and Nandi, S. (1992) Pregnancy-dependent to ovarian-independent progression in mammary tumors delineated in primary culture: Changes in signal transduction, growth factor regulation and matrix interaction. Cancer Res., 52, 6531-6538.
14. Hamamoto, S., Imagawa, W., Yang, J. and Nandi, S. (1987) Morphogenesis of mammary epithelial cells from virgin mice growing within collagen gels: Ultrastructural and immunocytochemical characterization. Cell Differ., 22, 191-202.
15. Levay-Young, B.K., Hamamoto, S., Imagawa, W. and Nandi, S. (1990) Casein accumulation in mouse mammary epithelial cells after growth stimulated by different hormonal and nonhormonal agents. Endocrinology, 126, 1173-1182.
16. Hinegardner, R. (1971) An improved fluorimetric assay for DNA. Anal. Biochem., 41, 477-487.
17. Reuter, C., Catling, A. and Weber, M. (1995) Immune complex kinase assays for mitogen-activated protein kinase and MEK. Methods Enzymol., 255, 245-279.
18. Imagawa, W., Spencer, E.M., Larson, L. and Nandi, S. (1986) SomatomedinC substitutes for insulin for the growth of mammary epithelial cells from normal virgin mice in serum-free collagen gel cell culture. Endocrinology, 119, 2695-2699.
19. Imagawa, W., Bandyopadhyay, G. and Nandi, S. (1995) Multifunctional phosphatidic acid signaling in mammary epithelial cells: Stimulation of phosphoinositide hydrolysis and conversion to diglyceride. J. Cell Physiol., 163, 561-569.
20. Dudley, D., Pang, L., Decker, S., Bridges, A. and Saltiel, A. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl Acad. Sci. USA, 92, 7686-7689.
21. Alessi, D., Smythe, C. and Keyse, S. (1993) The human CL100 gene encodes a tyr/thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in xenopus oocyte extracts. Oncogene, 8, 2015-2020.
22. mapk (ERK 1) by a thrombin and thrombin-receptor peptide agonist. Biochem. J., 289, 209-214.
23. Cook, S. and McCormick, F. (1996) Kinetic and biochemical correlation between sustained p44 ERK 1 (44 kDa extracellular signal-regulated kinase) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. Biochem. J., 320, 237-245.
24. 2+-dependent signal pathways in Rat-1 cells. J. Biol. Chem., 272, 13309-13319.
25. mapk (ERK1) by growth factors: Correlation between late phase activation and mitogenicity. Mot. Endocrinol., 6, 845-854.
26. Richards, J., Pasco, D., Yang, J., Guzman, R. and Nandi, S. (1983) Comparison of the growth of normal and neoplastic mouse mammary cells on plastic, on collagen gels and in collagen gels. Exp. Cell Res., 146, 1-14.
27. Robbins, D., Zhen, E., Cheng, M., Xu, S., Ebert, D. and Cobb, M. (1994) MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network. Adv. Cancer Res., 63, 93-117.
28. Lenormand, P., Sardet, C., Pages, G., L'Allemain, G., Brunet, A. and Pouyssegur, J. (1993) Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol., 122, 1079-1088.
29. Traverse, S., Seedorf, K., Paterson, H., Marshall, C., Cohen, P. and Ullrich, A. (1994) EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol., 4, 694-701.
30. Migliaccio, A., Di-Domenico, M., Castoria, G., de-Falco, A., Bontempo, P., Nola, E. and Auricchio, F. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J., 15, 1292-1300.
31. Mohamood, A., Gyles, P., Balan, G., Holis, V., Eckberg, E., Asseffa, A., Han, Z., Wyche, J. and Anderson, W. (1997) Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines. J. Submicrosc. Cytol. Pathol., 29, 1-17.
32. Chrysogelos, S., Yarden, R., Lauber, A. and Murphy, J. (1994) Mechanisms of EGF receptor regulation in breast cancer cells. Breast Cancer Res. Treat., 31, 227-236.
33. Coutts, A. and Murphy, L. (1998) Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res., 58, 4071-4074.
34. Huang, H., Nagane, M., Klingbeil, C., Lin, H., Nishikawa, R., Ji, X., Huang, C., Gill, G., Wiley, H. and Cavenee, W. (1997) The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem., 272, 2927-2935.
35. Griswold-Prenner, I., Carlin, C. and Rosner, M. (1993) Mitogen-activated protein kinase regulates the epidermal growth factor receptor through activation of a tyrosine phosphatase. J. Biol. Chem., 268, 13050-13054.
36. Morrison, P., Saltiel, A. and Rosner, M. (1996) Role of mitogen-activated protein kinase kinase in regulation of the epidermal growth factor receptor by protein kinase C. J. Biol. Chem., 271, 12891-12896.
37. Glasgow, W., Hui, R., Everhart, A., Jayawickreme, S.P., Angerman-Sterwart, J., Han, B.-B. and Eling, T. (1997) The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. J. Biol. Chem., 272, 19269-19276.
38. Tomic, S., Greiser, U., Lammers, R., Kharitonenkov, A., Imyanitov, E., Ullrich, A. and Bohmer, F.-D. (1995) Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. J. Biol. Chem., 270, 21277-21284.
39. McIntyre, B., Briski, K., Hosick, H. and Sylvester, P. (1998) Effects of protein tyrosine phosphatase inhibitors on EGF-and insulin-dependent mammary epithelial cell growth. Proc. Soc. Exp. Biol. Med., 217, 180-187.
40. Clark, E. and Brugge, J. (1995) Integrins and signal transduction pathways: the road taken. Science, 268, 233-239.
41. Morino, N., Mimura, T., Hamasaki, K., Tobe, K., Ueki, K., Kikuchi, K., Takehara, K., Kadowaki, T., Yazaki, Y. and Nojim, Y. (1995) Matrix/ integrin interaction activates the mitogen-activated protein kinase, p44erk-1 and p42erk-2. J. Biol. Chem., 270, 269-273.
42. Miyamoto, S., Teramoto, H., Gutkind, S. and Yamada, K. (1996) Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol., 135, 1633-1642.
43. Lin, T., Chen, Q., Howe, A. and Juliano, R. (1997) Cell anchorage permits efficient signal transduction between ras and its downstream kinases. J. Biol. Chem., 272, 8849-8852.
44. David, G. and Bernfield, M. (1981) Type I collagen reduces the degradation of basal lamina proteoglycan by mammary epithelial cells. J. Cell Biol., 91, 281-286.
45. Salomon, D.S., Liotta, L.A. and Kidwell, W.R. (1981) Differential response to growth factor by rat mammary epithelium plated on different collagen substrata in serum-free medium. Proc. Natl Acad. Sci. USA, 78, 382-386.
46. Fujii, K. (1996) Ligand activation of overexpressed epidermal growth factor receptor results in loss of epithelial phenotype and impaired RGD-sensitive integrin function in HSC-1 cells. J. Invest. Dermatol., 107, 195-202.
47. Tonks, N. and Neel, B. (1996) From form to function: Signaling by protein tyrosine phosphatases. Cell, 87, 365-368.
48. Groom, L., Sneddon, A., Alessi, D., Dowd, S. and Keyse, S. (1996) Differential regulation of the MAP, SAP and RK/p38 kinases by Pystl, a novel cytosolic dual-specificity phosphatase. EMBO J., 15, 3621-3632.